Jair Clarke - 01 Oct 2024 Form 4 Insider Report for OneMedNet Corp (ONMD)

Reporting relationship: Director
Issuer ticker: ONMD
Reported as of: 01 Oct 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Nov 2025, 21:54:48 UTC
Prior SEC filing: 03 Jun 2024
Next SEC filing: 23 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert Golden, Attorney-in-Fact

Key filing fact

Jair Clarke filed Form 4 for OneMedNet Corp (ONMD) on 26 Nov 2025.

Key facts

This page summarizes Jair Clarke's Form 4 filing for OneMedNet Corp (ONMD).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 Nov 2025, 21:54.

Change

Previous filing in this sequence was filed on 03 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001939502 Primary reporting owner

Clarke Jair

Relationship: Director
Address: 6385 OLD SHADY OAK ROAD, SUITE 250, EDEN PRAIRIE
Signature: /s/ Robert Golden, Attorney-in-Fact
Signature date: 26 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONMD transaction

Common Stock

Award

Transaction value: $0
Shares: +11,342
Change %
Price: $0.000000
Shares after: 11,342
Date: 01 Oct 2024
Ownership: Direct
Footnotes: F1

ONMD transaction

Common Stock

Award

Transaction value: $0
Shares: +82,143
Change %: +724%
Price: $0.000000
Shares after: 93,485
Date: 01 Jan 2025
Ownership: Direct
Footnotes: F2

ONMD transaction

Common Stock

Award

Transaction value: $0
Shares: +45,000
Change %: +48%
Price: $0.000000
Shares after: 138,485
Date: 26 Nov 2025
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024.

Footnote F2

Represents RSUs granted as director compensation under the 2022 Plan for service on the Commercial Committee. The RSUs vest as follows: (i) 50% of the RSU vest quarterly on the last day of each quarter for the applicable calendar year, subject to the reporting person's continued service with the issuer through each vesting date (the "Time Vesting Schedule"), and (ii) 50% of the RSUs vest on the Time Vesting Schedule if the issuer's revenue exceeds a specific threshold determined by the Board of Directors.

Footnote F3

Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.